MYCN and neuroblastoma: The SIOP Europe Neuroblastoma Group study demonstrated that boys with stage 1 disease without MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived) gene amplification suffered more relapse episodes during the 5-year follow-up period than did female patients93.